The global allergy immunotherapy market is expected to grow from USD 1.60 billion in 2019 to USD 3.18 billion by 2027, at a CAGR of 9.00% during the forecast period 2020-2027.
Allergy immunotherapy is a treatment for various types of allergies. It is known as hypo-sensitization or desensitization. It is beneficial in asthma, insect bites and environmental allergies. It is useful in changing the response from the immune system. It is highly used in improving allergy related quality of life, reducing symptomatic medication use and reducing symptoms. The allergy immunotherapy market is driven by an increased prevalence of disorders related to allergies. As these disorders are burdening the healthcare system, manufacturers are focusing more on research and development activities for novel therapies. Also, rise in the pollution resulted into prevalence of allergic disorders and asthma. Hence, it has led to drive the demand for allergy immunotherapy market.
This study delivers a comprehensive analysis of treatment types, allergy types and regions. The treatment type segment includes sublingual immunotherapy and subcutaneous immunotherapy. Subcutaneous immunotherapy segment is anticipated to have the highest growth in the market over the forecast period. It is a highly beneficial and effective treatment. It is majorly used in the treatment of stinging insect hypersensitivity, allergic asthma, rhinitis. It has an ability to manage various types of allergen. Higher adoption of the treatment is driving the growth of the market. Also, sublingual immunotherapy segment is expected to show a significant growth over the forecast period. Approval for liquid formulation is expected to boost the market. The allergy type segment includes allergic asthma and allergic rhinitis. Allergic rhinitis segment is anticipated to have the highest growth in the market over the forecast period. . Increased burden regarding allergic disorders on heathcare sector is a contributing factor to the growth of the market.
The market has been divided into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. Europe has the largest share in the market as the sublingual immunotherapy is highly preferred in the region. Europe is focusing more on research and development activities to offer safer and efficient practices in the region. Asia Pacific is also expected to show a significant share over the forecast period due to increased investment, standardization of dosage and presence of key players.
Some of the notable players in the allergy immunotherapy market are Circassia, Adamis Pharmaceuticals Corporation, Stallergenes Greer plc, ALK-Abelló A/S, HAL Allergy B.V., LETIPharma, DBV Technologies SA, ASIT Biotech, Mylan N.V., Allergy Therapeutics, DESENTUM OY, HollisterStier Allergy and Merck KGaA. ALK Abello A/S acquired Allergy Laboratory and Crystal Labs LLC. DBV Technologies partnered with Stallergenes S.A. for advanced research and development in birch allergy. Merck acquired BioControl in order to enhance the food safety testing.
This study forecasts revenue growth at global, regional, and country levels from 2020 to 2027. Fior Markets has segmented the market based on below-mentioned segments:
Global Allergy Immunotherapy Market Analysis And Forecast, By Treatment Type
Global Allergy Immunotherapy Market Analysis And Forecast, By Allergy Type
Global Allergy Immunotherapy Market Analysis And Forecast, By Regional Analysis
Report Description:
The market estimates have been evaluated by considering the effect of different political, economic, social, technological and legal factors which are based on our extensive secondary research, primary research, and in-house databases.
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis By Treatment Type
4.3.2. Market Attractiveness Analysis By Allergy Type
4.3.3. Market Attractiveness Analysis By Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.2.1. Rising prevalence of allergic disorders
5.3. Opportunities
5.3.1. A strong pipeline of immunotherapy products for treatment
5.4. Challenges
5.4.1. Complex allergies with higher morbidity
6. Global Allergy Immunotherapy Market Analysis and Forecast, By Treatment Type
6.1. Segment Overview
6.2. Sublingual Immunotherapy
6.3. Subcutaneous Immunotherapy
7. Global Allergy Immunotherapy Market Analysis and Forecast, By Allergy Type
7.1. Segment Overview
7.2. Allergic Asthma
7.3. Allergic Rhinitis
8. Global Allergy Immunotherapy Market Analysis and Forecast, By Regional Analysis
8.1. Segment Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.5. South America
8.5.1. Brazil
8.6. Middle East and Africa
8.6.1. UAE
8.6.2. South Africa
9. Global Allergy Immunotherapy Market-Competitive Landscape
9.1. Overview
9.2. Market Share of Key Players in Global Allergy Immunotherapy Market
9.2.1. Global Company Market Share
9.2.2. North America Company Market Share
9.2.3. Europe Company Market Share
9.2.4. APAC Company Market Share
9.3. Competitive Situations and Trends
9.3.1. Allergy Type Launches and Developments
9.3.2. Partnerships, Collaborations, and Agreements
9.3.3. Mergers & Acquisitions
9.3.4. Expansions
10. Company Profiles
10.1. Circassia
10.1.1. Business Overview
10.1.2. Company Snapshot
10.1.3. Company Market Share Analysis
10.1.4. Company Treatment Type Portfolio
10.1.5. Recent Developments
10.1.6. SWOT Analysis
10.2. Adamis Pharmaceuticals Corporation
10.2.1. Business Overview
10.2.2. Company Snapshot
10.2.3. Company Market Share Analysis
10.2.4. Company Treatment Type Portfolio
10.2.5. Recent Developments
10.2.6. SWOT Analysis
10.3. Stallergenes Greer plc
10.3.1. Business Overview
10.3.2. Company Snapshot
10.3.3. Company Market Share Analysis
10.3.4. Company Treatment Type Portfolio
10.3.5. Recent Developments
10.3.6. SWOT Analysis
10.4. ALK-Abelló A/S
10.4.1. Business Overview
10.4.2. Company Snapshot
10.4.3. Company Market Share Analysis
10.4.4. Company Treatment Type Portfolio
10.4.5. Recent Developments
10.4.6. SWOT Analysis
10.5. HAL Allergy B.V.
10.5.1. Business Overview
10.5.2. Company Snapshot
10.5.3. Company Market Share Analysis
10.5.4. Company Treatment Type Portfolio
10.5.5. Recent Developments
10.5.6. SWOT Analysis
10.6. LETIPharma
10.6.1. Business Overview
10.6.2. Company Snapshot
10.6.3. Company Market Share Analysis
10.6.4. Company Treatment Type Portfolio
10.6.5. Recent Developments
10.6.6. SWOT Analysis
10.7. DBV Technologies SA
10.7.1. Business Overview
10.7.2. Company Snapshot
10.7.3. Company Market Share Analysis
10.7.4. Company Treatment Type Portfolio
10.7.5. Recent Developments
10.7.6. SWOT Analysis
10.8. ASIT Biotech
10.8.1. Business Overview
10.8.2. Company Snapshot
10.8.3. Company Market Share Analysis
10.8.4. Company Treatment Type Portfolio
10.8.5. Recent Developments
10.8.6. SWOT Analysis
10.9. Mylan N.V.
10.9.1. Business Overview
10.9.2. Company Snapshot
10.9.3. Company Market Share Analysis
10.9.4. Company Treatment Type Portfolio
10.9.5. Recent Developments
10.9.6. SWOT Analysis
10.10. Allergy Therapeutics
10.10.1. Business Overview
10.10.2. Company Snapshot
10.10.3. Company Market Share Analysis
10.10.4. Company Treatment Type Portfolio
10.10.5. Recent Developments
10.10.6. SWOT Analysis
10.11. DESENTUM OY
10.11.1. Business Overview
10.11.2. Company Snapshot
10.11.3. Company Market Share Analysis
10.11.4. Company Treatment Type Portfolio
10.11.5. Recent Developments
10.11.6. SWOT Analysis
10.12. HollisterStier Allergy
10.12.1. Business Overview
10.12.2. Company Snapshot
10.12.3. Company Market Share Analysis
10.12.4. Company Treatment Type Portfolio
10.12.5. Recent Developments
10.12.6. SWOT Analysis
10.13. Merck KGaA
10.13.1. Business Overview
10.13.2. Company Snapshot
10.13.3. Company Market Share Analysis
10.13.4. Company Treatment Type Portfolio
10.13.5. Recent Developments
10.13.6. SWOT Analysis
List of Table
1. Global Allergy Immunotherapy Market, By Treatment Type, 2017-2027 (USD Billion) (K Units)
2. Global Sublingual Immunotherapy, Allergy Immunotherapy Market, By Region, 2017-2027 (USD Billion) (K Units)
3. Global Subcutaneous Immunotherapy, Allergy Immunotherapy Market, By Region, 2017-2027 (USD Billion) (K Units)
4. Global Allergy Immunotherapy Market, By Allergy Type, 2017-2027 (USD Billion) (K Units)
5. Global Allergic Asthma, Allergy Immunotherapy Market, By Region, 2017-2027 (USD Billion) (K Units)
6. Global Allergic Rhinitis, Allergy Immunotherapy Market, By Region, 2017-2027 (USD Billion) (K Units)
7. North America Allergy Immunotherapy Market, By Treatment Type, 2017-2027 (USD Billion) (K Units)
8. North America Allergy Immunotherapy Market, By Allergy Type, 2017-2027 (USD Billion) (K Units)
9. U.S. Allergy Immunotherapy Market, By Treatment Type, 2017-2027 (USD Billion) (K Units)
10. U.S. Allergy Immunotherapy Market, By Allergy Type, 2017-2027 (USD Billion) (K Units)
11. Canada Allergy Immunotherapy Market, By Treatment Type, 2017-2027 (USD Billion) (K Units)
12. Canada Allergy Immunotherapy Market, By Allergy Type, 2017-2027 (USD Billion) (K Units)
13. Mexico Allergy Immunotherapy Market, By Treatment Type, 2017-2027 (USD Billion) (K Units)
14. Mexico Allergy Immunotherapy Market, By Allergy Type, 2017-2027 (USD Billion) (K Units)
15. Europe Allergy Immunotherapy Market, By Treatment Type, 2017-2027 (USD Billion) (K Units)
16. Europe Allergy Immunotherapy Market, By Allergy Type, 2017-2027 (USD Billion) (K Units)
17. Germany Allergy Immunotherapy Market, By Treatment Type, 2017-2027 (USD Billion) (K Units)
18. Germany Allergy Immunotherapy Market, By Allergy Type, 2017-2027 (USD Billion) (K Units)
19. France Allergy Immunotherapy Market, By Treatment Type, 2017-2027 (USD Billion) (K Units)
20. France Allergy Immunotherapy Market, By Allergy Type, 2017-2027 (USD Billion) (K Units)
21. U.K. Allergy Immunotherapy Market, By Treatment Type, 2017-2027 (USD Billion) (K Units)
22. U.K. Allergy Immunotherapy Market, By Allergy Type, 2017-2027 (USD Billion) (K Units)
23. Italy Allergy Immunotherapy Market, By Treatment Type, 2017-2027 (USD Billion) (K Units)
24. Italy Allergy Immunotherapy Market, By Allergy Type, 2017-2027 (USD Billion) (K Units)
25. Spain Allergy Immunotherapy Market, By Treatment Type, 2017-2027 (USD Billion) (K Units)
26. Spain Allergy Immunotherapy Market, By Allergy Type, 2017-2027 (USD Billion) (K Units)
27. Asia Pacific Allergy Immunotherapy Market, By Treatment Type, 2017-2027 (USD Billion) (K Units)
28. Asia Pacific Allergy Immunotherapy Market, By Allergy Type, 2017-2027 (USD Billion) (K Units)
29. Japan Allergy Immunotherapy Market, By Treatment Type, 2017-2027 (USD Billion) (K Units)
30. Japan Allergy Immunotherapy Market, By Allergy Type, 2017-2027 (USD Billion) (K Units)
31. China Allergy Immunotherapy Market, By Treatment Type, 2017-2027 (USD Billion) (K Units)
32. China Allergy Immunotherapy Market, By Allergy Type, 2017-2027 (USD Billion) (K Units)
33. India Allergy Immunotherapy Market, By Treatment Type, 2017-2027 (USD Billion) (K Units)
34. India Allergy Immunotherapy Market, By Allergy Type, 2017-2027 (USD Billion) (K Units)
35. South America Allergy Immunotherapy Market, By Treatment Type, 2017-2027 (USD Billion) (K Units)
36. South America Allergy Immunotherapy Market, By Allergy Type, 2017-2027 (USD Billion) (K Units)
37. Brazil Allergy Immunotherapy Market, By Treatment Type, 2017-2027 (USD Billion) (K Units)
38. Brazil Allergy Immunotherapy Market, By Allergy Type, 2017-2027 (USD Billion) (K Units)
39. Middle East and Africa Allergy Immunotherapy Market, By Treatment Type, 2017-2027 (USD Billion) (K Units)
40. Middle East and Africa Allergy Immunotherapy Market, By Allergy Type, 2017-2027 (USD Billion) (K Units)
41. UAE Allergy Immunotherapy Market, By Treatment Type, 2017-2027 (USD Billion) (K Units)
42. UAE Allergy Immunotherapy Market, By Allergy Type, 2017-2027 (USD Billion) (K Units)
43. South Africa Allergy Immunotherapy Market, By Treatment Type, 2017-2027 (USD Billion) (K Units)
44. South Africa Allergy Immunotherapy Market, By Allergy Type, 2017-2027 (USD Billion) (K Units)
List of Figures
1. Global Allergy Immunotherapy Market Segmentation
2. Global Allergy Immunotherapy Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Allergy Immunotherapy Market Attractiveness Analysis by Treatment Type
9. Global Allergy Immunotherapy Market Attractiveness Analysis by Allergy Type
10. Global Allergy Immunotherapy Market Attractiveness Analysis by Region
11. Global Allergy Immunotherapy Market: Dynamics
12. Global Allergy Immunotherapy Market Share by Treatment Type (2020 & 2027)
13. Global Allergy Immunotherapy Market Share by Allergy Type (2020 & 2027)
14. Global Allergy Immunotherapy Market Share by Regions (2020 & 2027)
15. Global Allergy Immunotherapy Market Share by Company (2019)
Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.
Market research is valuable because of the following reasons:
Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.
Our market research process involves with the four specific stages.
Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:
Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:
Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.
This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.
Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.
Free Customization
Countries can be added on demand
Free yearly update on purchase of Multi/Corporate User License
Companies served till date
We serve our customers 24x7 for 365 days through calls, emails and live chat options.
Huge database of exceptional market reports bringing market intelligence to your fingertips.
SSL enabled, we offer you various secured payment options for risk free purchase.